Literature DB >> 10696099

Modulation of peristalsis by cannabinoid CB(1) ligands in the isolated guinea-pig ileum.

A A Izzo1, N Mascolo, M Tonini, F Capasso.   

Abstract

The effect of cannabinoid drugs on peristalsis in the guinea-pig ileum was studied. Peristalsis was induced by delivering fluid into the oral end of an isolated intestinal segment. Longitudinal muscle reflex contraction, threshold pressure and threshold volume to trigger peristalsis, compliance of the intestinal wall during the preparatory phase (a reflection of the resistance of the wall to distension) and maximal ejection pressure during the emptying phase of peristalsis were measured. The cannabinoid agonists WIN 55,212-2 (0.3 - 300 nM) and CP55,940 (0.3 - 300 nM) significantly decreased longitudinal muscle reflex contraction, compliance and maximal ejection pressure, while increased threshold pressure and volume to elicit peristalsis. These effects were not modified by the opioid antagonist naloxone (1 microM) and by the alpha-adrenoceptor antagonist phentolamine (1 microM). The inhibitory effect of both WIN 55,212-2 and CP55,940 on intestinal peristalsis was antagonized by the cannabinoid CB(1) receptor antagonist SR141716A (0.1 microM), but not by the cannabinoid CB(2) receptor antagonist SR144528 (0.1 microM). In absence of other drugs, the CB(1) receptor antagonists SR141716A (0.01 - 1 microM) and AM281 (0.01 - 1 microM) slightly (approximatively 20%) but significantly increased maximal ejection pressure during the empty phase of peristalsis without modifying longitudinal muscle reflex contraction, threshold pressure, threshold volume to trigger peristalsis and compliance. It is concluded that activation of CB(1) receptors reduces peristalsis efficiency in the isolated guinea-pig, and that the emptying phase of peristalsis could be tonically inhibited by the endogenous cannabinoid system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10696099      PMCID: PMC1571902          DOI: 10.1038/sj.bjp.0703116

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.

Authors:  R A Ross; H C Brockie; S R Fernando; B Saha; R K Razdan; R G Pertwee
Journal:  Br J Pharmacol       Date:  1998-11       Impact factor: 8.739

2.  Opioids modulate periodicity rather than efficacy of peristaltic waves in the guinea pig ileum in vitro.

Authors:  W Kromer; W Pretzlaff; R Woinoff
Journal:  Life Sci       Date:  1980-06-02       Impact factor: 5.037

3.  Hyoscine-resistant peristalsis in guinea-pig ileum.

Authors:  M Tonini; G Frigo; S Lecchini; L D'Angelo; A Crema
Journal:  Eur J Pharmacol       Date:  1981-05-22       Impact factor: 4.432

4.  Synergistic role of muscarinic acetylcholine and tachykinin NK-2 receptors in intestinal peristalsis.

Authors:  P Holzer; C A Maggi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-02       Impact factor: 3.000

5.  Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.

Authors:  D R Compton; L H Gold; S J Ward; R L Balster; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1992-12       Impact factor: 4.030

6.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Authors:  W A Devane; L Hanus; A Breuer; R G Pertwee; L A Stevenson; G Griffin; D Gibson; A Mandelbaum; A Etinger; R Mechoulam
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

7.  The role of enteric inhibitory motoneurons in peristalsis in the isolated guinea-pig small intestine.

Authors:  S A Waterman; M Costa
Journal:  J Physiol       Date:  1994-06-15       Impact factor: 5.182

8.  Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis.

Authors:  J R Grider
Journal:  Am J Physiol       Date:  1993-02

9.  Accommodation mediated by enteric inhibitory reflexes in the isolated guinea-pig small intestine.

Authors:  S A Waterman; M Costa; M Tonini
Journal:  J Physiol       Date:  1994-02-01       Impact factor: 5.182

10.  Calcium entry blockade as a mechanism for chlordimeform-induced inhibition of motor activity in the isolated guinea-pig ileum.

Authors:  S M Candura; P Marraccini; L G Costa; L Manzo; A Rossi; T Coccini; M Tonini
Journal:  Pharmacol Toxicol       Date:  1992-12
View more
  12 in total

Review 1.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.

Authors:  Aaron M D'Antona; Kwang H Ahn; Debra A Kendall
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

3.  Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.

Authors:  Fabio Guagnini; Paola Cogliati; Sylvain Mukenge; Gianfranco Ferla; Tiziano Croci
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

4.  Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice.

Authors:  Mauro A M Carai; Giancarlo Colombo; Gian Luigi Gessa; Ratnakumar Yalamanchili; Balapal S Basavarajappa; Balapal S Basavarajppa; Basalingappa L Hungund
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

Review 5.  Complementary Therapies in Inflammatory Bowel Diseases.

Authors:  Henit Yanai; Nir Salomon; Adi Lahat
Journal:  Curr Gastroenterol Rep       Date:  2016-12

6.  Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.

Authors:  R Makwana; A Molleman; M E Parsons
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

7.  Effect of vanilloid drugs on gastrointestinal transit in mice.

Authors:  A A Izzo; R Capasso; L Pinto; G Di Carlo; N Mascolo; F Capasso
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

8.  Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil.

Authors:  A A Izzo; L Pinto; F Borrelli; R Capasso; N Mascolo; F Capasso
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

9.  Influence of the CB(1) receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 10.  Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.

Authors:  K L Wright; M Duncan; K A Sharkey
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.